Sandbox leucocytosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 458: | Line 458: | ||
{| | {| | ||
|- | |- | ||
! colspan=" | ! colspan="4" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Surface Lesions of Oral Mucosa | ||
! | |||
! | |||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 465: | Line 467: | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
|- | |- | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" rowspan="16" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* | * White | ||
| rowspan="11" |Epithelial | |||
|Geographic tongue | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 473: | Line 478: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | |Hairy tongue | ||
* | | | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Leukoedema | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|White sponge nevus | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Hairy leukoplakia | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Lichen planus | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Nicotinic stomatitis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Hyperkeratosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Epithelial dysplasia | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Carcinoma in-situ | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Squamous cell carcinoma | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="2" |Surface debris | |||
|Candidiosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Burn | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="3" |Subepithelial | |||
|Congenital keratotic cyst | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Scar | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Fordyce granules | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| colspan="3" rowspan="20" | | |||
* Pigmented | |||
| rowspan="11" |Localized | |||
| rowspan="3" |Intravascular | |||
|Hemangioma | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Varix | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Kaposi sarcoma | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="3" |Extravasated blood | |||
|Hematoma | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Ecchymosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Petechiae | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="4" |Melanocytic | |||
|Oral melanocytic macule | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Nevus | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Melanoma | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Ephelis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Tattoo | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="9" |Diffuse | |||
|Hereditary | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Addison's disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Heavy metal ingestion | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Peutz-Jeghers syndrome | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Neurofibromatosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Polyostotic fibrous dysplasia | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Pregnancy | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Medication | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Smoker's melanosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| colspan="3" rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: left;" | | |||
* Vesicular/Ulcerative/Erythematous | |||
|Hereditary | |||
|Epidermolysis bullosa | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 480: | Line 767: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| rowspan="6" |Viral | |||
|Herpes simplex | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Herpangina | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Hand foot and mouth disease | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Herpes zoster | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Infectious mononucleosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Varicella | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="5" |Autoimmune | |||
|Erosive lichen planus | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Mucous memrane pemphigoid | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Pemphigous vulgaris | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Bullous pemphigoid | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Lupus erythmatosus | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="5" |Idiopathic | |||
|Aphthous ulcer | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Erythema multiforme | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Erythroplakia | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Medication induced mucositis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Contact stomatitis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Mycotic | |||
|Candidiosis | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
! colspan=" | ! colspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign Oral lesions | ||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 490: | Line 918: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pyogenic granuloma | * Pyogenic granuloma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 498: | Line 929: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peripheral ossifying fibroma | * Peripheral ossifying fibroma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 506: | Line 940: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Granular cell tumor | * Granular cell tumor | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 514: | Line 951: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peripheral giant cell granuloma | * Peripheral giant cell granuloma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 522: | Line 962: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral hemangioma | * Oral hemangioma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 532: | Line 975: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Traumatic neuroma | * Traumatic neuroma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 540: | Line 986: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Neurofibroma | * Neurofibroma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 548: | Line 997: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Schwannoma | * Schwannoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 554: | Line 1,006: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left; | | colspan="2" rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Palisaded encapsulated neuroma | * Palisaded encapsulated neuroma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 562: | Line 1,017: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 570: | Line 1,028: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Neodymium-doped yttrium alluminium garnet | * Neodymium-doped yttrium alluminium garnet | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 578: | Line 1,039: | ||
| rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pigmented lesions | * Pigmented lesions | ||
| rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Diffuse | * Diffuse | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peutz-jeghers syndrome | * Peutz-jeghers syndrome | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 588: | Line 1,052: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Addison's disease | * Addison's disease | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 596: | Line 1,063: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Heavy metal | * Heavy metal | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 604: | Line 1,074: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Drug induced | * Drug induced | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 612: | Line 1,085: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Post inflammatory | * Post inflammatory | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 620: | Line 1,096: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Smoker's melanosis | * Smoker's melanosis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 630: | Line 1,109: | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Focal | * Focal | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Ephelides | * Ephelides | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 638: | Line 1,120: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Labial melanocytic macules | * Labial melanocytic macules | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 646: | Line 1,131: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Amalgam tattoo | * Amalgam tattoo | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 654: | Line 1,142: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral melanoacanthoma | * Oral melanoacanthoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 662: | Line 1,153: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral melanocytic nevi | * Oral melanocytic nevi | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 671: | Line 1,165: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pre-malignant oral lesions | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pre-malignant oral lesions | ||
! | |||
! | |||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 679: | Line 1,176: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Leukoplakia | * Leukoplakia | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 687: | Line 1,187: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral proliferative verrucous leukoplakia | * Oral proliferative verrucous leukoplakia | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 695: | Line 1,198: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erythroplakia | * Erythroplakia | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 703: | Line 1,209: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral submucus fibrosis | * Oral submucus fibrosis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 711: | Line 1,220: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral lichen planus and lichenoid lesions | * Oral lichen planus and lichenoid lesions | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 719: | Line 1,231: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral discoid lupus erythmatosus | * Oral discoid lupus erythmatosus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 727: | Line 1,242: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral chronic graft vs host disease | * Oral chronic graft vs host disease | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 735: | Line 1,253: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Actinic chelitis | * Actinic chelitis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 742: | Line 1,263: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant oral lesions | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant oral lesions | ||
! | |||
! | |||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 752: | Line 1,276: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Squamous cell carcinoma | * Squamous cell carcinoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 760: | Line 1,287: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Basal cell carcinoma | * Basal cell carcinoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 768: | Line 1,298: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Verrucous crcinoma | * Verrucous crcinoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 776: | Line 1,309: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Spindle cell carcinoma | * Spindle cell carcinoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 784: | Line 1,320: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Adenoid squamous cell carcinoma | * Adenoid squamous cell carcinoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 792: | Line 1,331: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lymphoepithelioma and transitional cell carcinoma | * Lymphoepithelioma and transitional cell carcinoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 800: | Line 1,342: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Malignant melanoma | * Malignant melanoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 810: | Line 1,355: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Malignant schwannoma | * Malignant schwannoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 820: | Line 1,368: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Leiomyosarcoma | * Leiomyosarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 828: | Line 1,379: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Rhabdomyosarcoma | * Rhabdomyosarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 838: | Line 1,392: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Malignant lymphoma | * Malignant lymphoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 846: | Line 1,403: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Non Hodgkin lymphoma | * Non Hodgkin lymphoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 854: | Line 1,414: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hodgkin lymphoma | * Hodgkin lymphoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 862: | Line 1,425: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
*Burkitt's lymphoma | *Burkitt's lymphoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 870: | Line 1,436: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Reticular cell sarcoma | * Reticular cell sarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 878: | Line 1,447: | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Plasma cell tumor | * Plasma cell tumor | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Multiple myeloma | * Multiple myeloma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 886: | Line 1,458: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;"| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Plasmacytoma | * Plasmacytoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 898: | Line 1,473: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Fibrosarcoma | * Fibrosarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 906: | Line 1,484: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Liposarcoma | * Liposarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 916: | Line 1,497: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Granular cell myoblastoma | * Granular cell myoblastoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 924: | Line 1,508: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Congenital epulis | * Congenital epulis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 932: | Line 1,519: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Alveolar soft part sarcoma | * Alveolar soft part sarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 940: | Line 1,530: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Melanocytic neuroectodermal tumor of infancy | * Melanocytic neuroectodermal tumor of infancy | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 948: | Line 1,541: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Kaposi sarcoma | * Kaposi sarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 956: | Line 1,552: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Ewing's sarcoma | * Ewing's sarcoma | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 963: | Line 1,562: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infections | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infections | ||
! | |||
! | |||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 971: | Line 1,573: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpes simplex virus | * Herpes simplex virus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 979: | Line 1,584: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Varicella zoster virus | * Varicella zoster virus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 987: | Line 1,595: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Coxsackie virus | * Coxsackie virus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 995: | Line 1,606: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* HIV infection | * HIV infection | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,003: | Line 1,617: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Syphilis | * Syphilis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,011: | Line 1,628: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Other infections | * Other infections | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,018: | Line 1,638: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autoimmune Conditions | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autoimmune Conditions | ||
! | |||
! | |||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 1,026: | Line 1,649: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral erosive lichen planus | * Oral erosive lichen planus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,034: | Line 1,660: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Systemic lupus erythamtosus | * Systemic lupus erythamtosus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,042: | Line 1,671: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mucus membrane pemphigoid | * Mucus membrane pemphigoid | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,050: | Line 1,682: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Bullous pemphigoid | * Bullous pemphigoid | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,058: | Line 1,693: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pemphigus vulgaris | * Pemphigus vulgaris | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,066: | Line 1,704: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Paraneoplastic pemphigus | * Paraneoplastic pemphigus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,074: | Line 1,715: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epidermolysis bullosa acquisita | * Epidermolysis bullosa acquisita | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,081: | Line 1,725: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Miscellaneous | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Miscellaneous | ||
! | |||
! | |||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 1,089: | Line 1,736: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Burning mouth syndrome | * Burning mouth syndrome | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,097: | Line 1,747: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Contact stomatitis | * Contact stomatitis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,105: | Line 1,758: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Cheilitis | * Cheilitis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,113: | Line 1,769: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mucoceles | * Mucoceles | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,121: | Line 1,780: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Torus | * Torus | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,129: | Line 1,791: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Dental erosions/Gingival overgrowth | * Dental erosions/Gingival overgrowth | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,137: | Line 1,802: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Telangiectasias | * Telangiectasias | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,144: | Line 1,812: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: left;" |Tongue lesions | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: left;" |Tongue lesions | ||
! | |||
! | |||
! | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 1,152: | Line 1,823: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Atrophic glossitis | * Atrophic glossitis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,160: | Line 1,834: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Fissured tongue | * Fissured tongue | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,168: | Line 1,845: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Black tongue | * Black tongue | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,176: | Line 1,856: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Black hairy tongue | * Black hairy tongue | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,184: | Line 1,867: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pigmented fungiform papillae of the tongue | * Pigmented fungiform papillae of the tongue | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,192: | Line 1,878: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Geographic tongue | * Geographic tongue | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,200: | Line 1,889: | ||
| colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Median rhomboid glossitis | * Median rhomboid glossitis | ||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 05:48, 24 January 2019
Disease | Presentation | Risk Factors | Diagnosis | Affected Organ Systems | Important features | Picture |
---|---|---|---|---|---|---|
Diseases predominantly affecting the oral cavity | ||||||
Oral Candidiasis |
|
|
|
Localized candidiasis
Invasive candidasis |
|
|
Herpes simplex oral lesions |
|
|
|
|
||
Aphthous ulcers |
|
|
|
|
|
|
Squamous cell carcinoma |
|
|
||||
Leukoplakia |
|
|
|
|
||
Melanoma |
|
|
|
|
||
Fordyce spots |
|
|
|
|
||
Burning mouth syndrome |
|
|
||||
Torus palatinus |
|
|||||
Diseases involving oral cavity and other organ systems | ||||||
Behcet's disease |
|
|
|
|||
Crohn's disease |
|
|
|
|||
Agranulocytosis |
|
|
||||
Syphilis |
|
|
|
|||
Coxsackie virus |
|
|
||||
Chicken pox |
|
|
|
|
||
Measles |
|
|
|
|
Surface Lesions of Oral Mucosa | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Epithelial | Geographic tongue | ||||||||
Hairy tongue | ||||||||||
Leukoedema | ||||||||||
White sponge nevus | ||||||||||
Hairy leukoplakia | ||||||||||
Lichen planus | ||||||||||
Nicotinic stomatitis | ||||||||||
Hyperkeratosis | ||||||||||
Epithelial dysplasia | ||||||||||
Carcinoma in-situ | ||||||||||
Squamous cell carcinoma | ||||||||||
Surface debris | Candidiosis | |||||||||
Burn | ||||||||||
Subepithelial | Congenital keratotic cyst | |||||||||
Scar | ||||||||||
Fordyce granules | ||||||||||
|
Localized | Intravascular | Hemangioma | |||||||
Varix | ||||||||||
Kaposi sarcoma | ||||||||||
Extravasated blood | Hematoma | |||||||||
Ecchymosis | ||||||||||
Petechiae | ||||||||||
Melanocytic | Oral melanocytic macule | |||||||||
Nevus | ||||||||||
Melanoma | ||||||||||
Ephelis | ||||||||||
Tattoo | ||||||||||
Diffuse | Hereditary | |||||||||
Addison's disease | ||||||||||
Heavy metal ingestion | ||||||||||
Peutz-Jeghers syndrome | ||||||||||
Neurofibromatosis | ||||||||||
Polyostotic fibrous dysplasia | ||||||||||
Pregnancy | ||||||||||
Medication | ||||||||||
Smoker's melanosis | ||||||||||
|
Hereditary | Epidermolysis bullosa | ||||||||
Viral | Herpes simplex | |||||||||
Herpangina | ||||||||||
Hand foot and mouth disease | ||||||||||
Herpes zoster | ||||||||||
Infectious mononucleosis | ||||||||||
Varicella | ||||||||||
Autoimmune | Erosive lichen planus | |||||||||
Mucous memrane pemphigoid | ||||||||||
Pemphigous vulgaris | ||||||||||
Bullous pemphigoid | ||||||||||
Lupus erythmatosus | ||||||||||
Idiopathic | Aphthous ulcer | |||||||||
Erythema multiforme | ||||||||||
Erythroplakia | ||||||||||
Medication induced mucositis | ||||||||||
Contact stomatitis | ||||||||||
Mycotic | Candidiosis | |||||||||
Benign Oral lesions | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|
||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Pre-malignant oral lesions | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Malignant oral lesions | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
|
|||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|||||||||
|
|
|||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Infections | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Autoimmune Conditions | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Miscellaneous | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Tongue lesions | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
Type of cancer | Subtype | Epidemiology | Localization | Clinical features | Diagnostic procedures |
---|---|---|---|---|---|
Squamous cell carcinoma
|
Verrucous carcinoma |
|
|
|
Biopsy shows:
Thickened club-shaped papillae and blunt stromal invaginations of well-differentiated squamous epithelium with marked keratinization |
Lymphoepithelial carcinoma | 0.8-2% of all oral or oropharyngeal cancers |
|
|
Biopsy chows:
| |
Epithelial precursor lesions | --- | --- | Seen in the entire digestive tract |
|
Biopsy shows:
|
Proliferative verrucous leukoplakia and precancerous conditions | --- |
|
|
An aggressive form of oral leukoplakia with considerable morbidity and
strong predilection to malignant transformation |
Biopsy shows:
|
Papillomas | Squamous cell papilloma and |
|
Any oral site may be affected mostly:
|
Soft, pedunculated lesions formed by a cluster of finger-like fronds or a sessile, dome-shaped lesion with a nodular, papillary or verrucous surface | Biopsy shows:
|
Condyloma acuminatum | 2nd and 5th decade with a peak in teenagers and young adults |
|
Biopsy shows:
Several sessile, cauliflower-like swellings forming a cluster | ||
Focal epithelial hyperplasia | Disease of children, adolescents and young adults |
|
|
Biopsy shows:
| |
Granular cell tumor | --- |
|
|
|
Biopsy shows:
|
Keratoacanthoma | --- |
whites
men as in women |
|
|
Biopsy shows:
|
Papillary hyperplasia | --- | Affects all age groups | Palate | Asymptomatic nodular or papillary mucosal lesion | Biopsy shows:
|
Median rhomboid glossitis | --- | --- | Dorsum of the tongue at the junction of the anterior two thirds
and posterior third |
Forms a patch of papillary atrophy in the region of the
embryological foramen caecum |
Biopsy shows:
|
Salivary gland tumors | Acinic cell carcinoma |
|
Tumors usually
form non-descript swellings |
Biopsy shows:
| |
Mucoepidermoid carcinoma |
|
|
|
Low power microscopy shows low-grade tumor with both cystic and solid areas and an inflamed, fibrous stroma | |
Adenoid cystic carcinoma |
|
|
Predominantly solid variant shows peri- and intraneural invasion | ||
Epithelial-myoepithelial
carcinoma |
--- | --- | --- | --- | |
Clear cell carcinoma,
NOS |
--- | --- | --- | ||
Basal cell | Rare in minor glands | Asymptomatic, smooth or lobulated sub-mucosal masses | Microscopically similar to basal
cell adenocarcinomas of the major gland | ||
Cystadenocarcinoma | 32% developed in the minor glands |
|
Slow growing and painless but
some palatal tumors may erode the underlying bone causing sinonasal complex |
--- | |
Salivary duct carcinoma |
|
|
Tumors formed painless swellings but many in the palate can be painful and ulcerated or fungated with metastases to regional lymph nodes | The range of
microscopical appearances is similar to that seen in the major glands | |
Salivary gland adenomas | Pleomorphic adenoma | 40-70% of minor gland tumors |
|
Painless, slow growing, submucosal masses, but when | Biopsy shows cellular, and hyaline or plasmacytoid cell |
Myoepithelioma | 42% of minor gland tumors |
|
--- | --- | |
Basal cell adenoma | 20% of minor gland tumors | --- | They are histologically
similar to those in major glands. | ||
Cystadenoma | 7% of benign minor gland tumors | --- | --- | ||
Kaposi sarcoma | --- |
|
|
Biopsy of all 4 types show:
| |
Lymphangioma | --- |
|
Tongue |
|
Biopsy shows:
|
Ectomesenchymal chondromyxoid
tumour of the anterior tongue |
--- |
|
--- | Asymptomatic, slow growing solitary nodule in the anterior dorsal tongue | Biopsy shows:
|
Focal oral mucinosis (FOM) | --- |
|
Asymptomatic fibrous or cystic-like lesion | Histopathology is characterized by:
| |
Congenital granular cell epuli | --- |
|
Solitary, somewhat pedunculated fibroma-like lesion attached to the alveolar
ridge near the midline |
||
Hematolymphoid tumors | Non-Hodgkin lymphoma | Second most common cancer of the oral cavity |
|
NHL of the lip presents with:
|
Biopsy shows:
|
Langerhans cell histiocytosis | --- |
and |
Common oral symptoms
include:
|
Biopsy shows ovoid Langerhans cells
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |
Hodgkin lymphoma | --- |
|
Most patients present with localized disease (stage I/II), with
|
--- | |
Extramedullary myeloid
sarcoma |
--- | Isolated tumor-forming intraoral mass | Biopsy shows an Indian-file pattern of infiltration | ||
Follicular dendritic cell
sarcoma / tumour |
|
|
The patients usually
present with a painless mass |
Biopsy usually exhibits
borders and comprises:
| |
Mucosal malignant melanoma | --- |
|
80% arise:
Others:
|
|
|